Abstract
Declines in cervical cancer incidence and mortality reported in the United States since the 1950s have been attributed to early detection and treatment of precancerous and cancerous lesions through the use of the Papanicolaou (Pap) test (1). More than 50 million Pap tests are performed each year (2); however, guidelines about the frequency of testing in women with a history of normal test results are inconsistent (3-5). To determine the incidence of cervical cytologic abnormalities following a normal Pap test, 1991-1998 data from the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) were analyzed for this report (6). The findings indicated that within 3 years of a normal Pap test result, severe cytologic abnormalities were uncommon, and incidence rates were similar among women screened 1, 2, and 3 years following a normal Pap test.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.